Curriculum Vitae

DR. AHMAD NAZRAN BIN FADZLI

Medical Lecturer
  • Department of Surgery
    Faculty of Medicine
  • +603-79492441

AREAS OF EXPERTISE


ACADEMIC QUALIFICATION


  • MSurg(UM)(2012), (Surgeri)
    Universiti Malaya (UM)
  • MBChB(2006), (Perubatan dan Pembedahan)
    University of Leicester, Leicester, Uk
  • Expert Training, (Farmasi Klinikal)
    University of Leicester, Leicester, Uk

ADMINISTRATIVE DUTIES


  • Deputy Chairman
    12 Jan 2021 - 31 Dec 2022 (National)
  • Coordinator
    16 Jan 2019 - 31 Dec 2019 (Faculty)

MEMBERSHIPS


  • PHASE 1 CO-ORDINATOR , COMMITTEE MEMBER
    2021 to 2023 (University)
  • DEPUTY CHAIRMAN, VICE PRESIDENT
    2021 to 2022 (National)
  • SCIENTIFIC CHAIRMAN ENDOUROLOGY IN THE COVID ERA, COMMITTEE MEMBER
    2021 to 2021 (International)
  • CO-SCIENTIFIC CHAIRMAN 30TH MALAYSIAN UROLOGICAL CONFERENCE (VIRTUAL), COMMITTEE MEMBER
    2021 to 2021 (International)

PUBLICATIONS


Article in Journal
  1. Yii RSL et al., Predictive factors of prostate cancer diagnosis with PSA 4.0e10.0 ng/ml in a multi-ethnic Asian population, Malaysia, Asian Journal of Surgery, https://doi.org/10.1016/j.asjsur.2019.02.014
  2. NY Yap, R Rajandram, KL Ng, J Pailoor, A Fadzli, GC Gobe. Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms. Biomed Research International 2015 (2015), Article ID 476508, 22 pages.

RESEARCH PROJECT


International
  1. 2019 - 2024, Merck Sharp & Dohme (M) Sdn. Bhd
    KEYNOTE-676 : Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette-Guerin (BCG) in Participants with High-risk Non-muscle Invasive Bladder Cancer (HR NMIBC) that is Persistent or Recurrent Following BCG Induction (KEYNOTE-676) ( Consultant)
  2. 2015 - 2020, International Funding
    A multi-centre, prospective, longitudinal registry of patients with prostate cancer in Asia ( Consultant)
  3. 2016 - 2019, International Funding
    A Phase I V Interventional Safety, Efficacy and Quality of Life Study of ELIGARD in Prostate Cancer Patients in Asia (ELIGANT) ( Consultant)
  4. 2018 - 2018, International Funding
    Robotic-a ssisted percutaneous access Interventional, non-randomized, open-label, non-comparative and First-in-Man Study ( Consultant)
  5. 2008 - 2008, Sanofi-Aventis
    SAVE-ONCO: A multinational, randomized, double- blind, placebo-controlled study to evaluate the efficacy and safety of AVE5026 in the prevention of venous throboembolism (VTE) in cancer patients at high risk for VTE and who are undergoing chemotherapy ( Coordinator)

PAPER PRESENTED


INVITED SPEAKER
  1. Nocturia, Malaysian Enterostomal Therapy Nursing Education Programme, M&T Network Consultancy Services Sdn Bid (National) (06 Sep 2021 - 27 Nov 2021)
POSTER PRESENTER
  1. metastatic RCC to contralateral ureter, Malaysian Urological COnference, MUA (National) (24 Nov 2016 - 27 Nov 2016)
  2. Efficacy of Oral Chondroitin Sulphate (urosulf) in Reducing Ureteric Stent Related Symptoms, 14th Urological Association of Asia Congress 2016, UAA & SUA (International) (20 Jul 2016 - 24 Jul 2016)
  3. Percutaneous Nephrolithotomy (PCNL) in a case of Horseshoe Kidney, 27th World Congress on Videourology & Clinical Urology, Thai Urological Association (International) (09 Jun 2016 - 12 Jun 2016)
  4. Ultra-Mini Percutaneous Nephrolithotripsy: A UMMC Experience, Malaysian Urology Conference, MUC (National) (20 Nov 2015 - 22 Nov 2015)
  5. Transrectal Ultrasound Guided Prostate Biopsy Complications - a UMMC experience, 23rd Malaysian Urological Conference, Malaysian Urological Association (National) (21 Nov 2014 - 23 Nov 2014)
  6. Tubulocystic renal cell carcinoma presenting as spontaneous subcapsular haematoma, 22nd Malaysian Urological Conference, Malaysian Urological Association (National) (22 Nov 2013 - 24 Nov 2013)
PRESENTER
  1. hair in urethra post scrotal skin hypospadias repair, Malaysian urological conference, MUA (National) (24 Dec 2017 - 26 Dec 2017)

ACADEMIC/PROFESSIONAL SERVICES


Evaluation
  1. (2021) Board Examination for Malaysian Urological Trainees, National, (Internal Examiner)

SOCIAL RESPONSIBILITY ACTIVITIES


  • Awani Pagi: Bulan Kesedaran Kesihatan Lelaki Sedunia, (30 Nov 2019 - 30 Nov 2019)